Dr. Karen Smith
Board Member
Aurinia Pharmaceuticals Inc. (AUPH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Karen Smith
Dr. Karen Smith is recorded as Board Member at Aurinia Pharmaceuticals Inc. (AUPH). Aurinia Pharmaceuticals Inc. reported in an 8-K filed August 21, 2023 that Dr. Karen Smith was appointed Board of Directors, effective August 18, 2023.
“Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia's Board of Directors August 18, 2023”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-18–present
-
Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement
Start not stated–2024-05-03
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aurinia Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Michael Hearne CFO
- Matthew Donley COO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Robert T. Foster Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.